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Abstract
Background We previously initiated a randomized con-
trolled trial to test the effectiveness of two self-refer-
ral reminders and a theory-based leaflet (sent 12 and 
24 months after the initial invitation) to increase participa-
tion within the English Bowel Scope Screening program.
Purpose This study reports the results following the sec-
ond reminder.
Methods Men and women included in the initial sam-
ple (n = 1,383) were re-assessed for eligibility 24 months 
after their invitation (12 months after the first reminder) 
and excluded if  they had attended screening, moved 
away, or died. Eligible adults received the same treat-
ment they were allocated 12  months previous, that is, 
no reminder (“control”), or a self-referral reminder with 
either the standard information booklet (“Reminder and 
Standard Information Booklet”) or theory-based leaflet 
designed using the Behavior Change Wheel (“Reminder 
and Theory-Based Leaflet”). The primary outcome was 
the proportion screened within each group 12  weeks 
after the second reminder.
Results In total, 1,218 (88.1%) individuals were eligible. 
Additional uptake following the second reminder was 
0.4% (2/460), 4.8% (19/399), and 7.9% (29/366) in the 
control, Reminder and Standard Information Booklet, 
and Reminder and Theory-Based Leaflet groups, respec-
tively. When combined with the first reminder, the 
overall uptake for each group was 0.7% (3/461), 14.5% 
(67/461), and 21.5% (99/461). Overall uptake was signifi-
cantly higher in the Reminder and Standard Information 
Booklet and Reminder and Theory-Based Leaflet groups 
than in the control (odds ratio [OR] = 26.1, 95% confi-
dence interval [CI] = 8.1–84.0, p < .001 and OR = 46.9, 
95% CI = 14.7–149.9, p < .001, respectively), and signifi-
cantly higher in the Reminder and Theory-Based Leaflet 
group than in the Reminder and Standard Information 
Booklet group (OR = 1.8, 95% CI = 1.3–2.6, p < .001).
Conclusion A second reminder increased uptake among 
former nonparticipants. The added value of the theo-
ry-based leaflet highlights a potential benefit to review-
ing the current information booklet.
Trials Registry Number ISRCTN44293755.
Keywords  Colorectal cancer • Screening • Uptake • 
Flexible sigmoidoscopy • Behavioral science
Introduction
Colorectal cancer is a leading cause of morbidity and 
mortality throughout the world [1]. Several large rand-
omized controlled trials have shown that a single flexible 
Robert Kerrison
robert.kerrison.13@ucl.ac.uk
1 Research Department of Behavioural Science and Health, 
University College London, London, UK
2 Cancer Research UK & UCL Cancer Trials Centre, 
University College London, London, UK
3 St Mark’s Bowel Cancer Screening Centre, St Mark’s 
Hospital, Middlesex, UK
4 Partners in Creation, Top Studio, London, UK
5 South Tyneside NHS Foundation Trust, South Tyneside 
School of Medicine, Pharmacy and Health, Durham 
University, Durham, UK
ann. behav. med. (2018) 52:941–951
DOI: 10.1093/abm/kax068
D
ow
nloaded from
 https://academ
ic.oup.com
/abm
/article-abstract/52/11/941/4810414 by U
niversity of N
ew
castle user on 23 January 2019
sigmoidoscopy screen between the ages of 55 and 64 
can significantly reduce the incidence and mortality of 
the disease among people who complete the test [2]. As 
a result, several countries have begun piloting flexible 
sigmoidoscopy-based screening programs for the pre-
vention of colorectal cancer [3], with England currently 
rolling out a national program (referred to as the Bowel 
Scope Screening program) set to reach full population 
coverage in 2018.
One of the key determinants of successful screening 
programs is the ability to achieve high population up-
take. In England, all screening and treatment is offered 
automatically and free of charge through the National 
Health Service. However, despite being offered automat-
ically and for free, the uptake of bowel scope screening is 
both low and socioeconomically graded [4]. One recent 
study found that only 43% of men and women invited 
for bowel scope screening during the initial implementa-
tion of the program attended an appointment, and that 
uptake was lowest among individuals living in the most 
deprived areas (uptake ranged from 32% in the most 
deprived areas to 52% in the least deprived) [4]. This is 
not a problem exclusive to the UK [5]. In the USA, for 
example, nearly half  (48%) of eligible adults are not up 
to date with screening recommendations, despite avail-
able guidelines and evidence demonstrating their effect-
iveness [6].
As with other screening programs, the National 
Health Service bowel scope screening program incorpo-
rates specific strategies to maximize uptake (e.g., preno-
tification letters, reminder letters, timed appointments) 
[7–9]. Invitees receive a prenotification letter shortly 
after their 55th birthday. They then receive an invitation 
with a timed appointment 2  weeks thereafter. Anyone 
who does not respond to their invitation within 2 weeks 
is sent a reminder. If  there is no response within an add-
itional 2 weeks, the appointment is cancelled, and the in-
dividual is notified via direct mail. Anyone who confirms 
an appointment, but does not attend, is similarly noti-
fied. In both cases, the recipient is informed that they can 
self-refer for bowel scope screening up until age of 60, 
when they are eligible for a fecal occult blood test once 
every 2 years up until the age of 74.
Previous research exploring nonparticipation and 
decision making in the English Bowel Scope Screening 
program has identified a number of barriers to uptake, 
including “a perceived or actual lack of need to have the 
test”, “an inability to attend the appointment offered”, 
and “a lack of understanding about the harms and bene-
fits of screening” [10]. One of the subsequent suggestions 
to improve uptake has been to send nonparticipants an 
additional reminder at a later date [10], and already there 
is some evidence to suggest that this may be effective [11].
We ourselves have previously examined the feasibil-
ity of sending bowel scope screening nonparticipants a 
reminder letter and leaflet 12 months after their initial 
invitation [11]. More specifically, we have previously 
investigated the feasibility of sending nonparticipants a 
theory-based leaflet (designed according to principles put 
forth by the Behavior Change Wheel) [12] and reminder 
letter (hereafter referred to as a “self-referral reminder”) 
that gave instructions for how to self-refer and included 
options for the day and time of the appointment and the 
gender of the practitioner performing the test [11]. On 
the basis that: (i) the reminder letter and leaflet could be 
implemented and (ii) would be more effective if  sent a 
second time (i.e., 24 months after the initial invitation) 
[13–15], we performed a formal randomized controlled 
trial to test their effectiveness against usual care (i.e., no 
reminder).
Results from the first stage of the randomized con-
trolled trial (i.e., the first reminder) demonstrated that 
sending nonparticipants a single self-referral reminder, 
12  months after their initial invitation, significantly 
increased participation against usual care, and that 
reminders were more effective when sent with the theo-
ry-based leaflet, as opposed to the standard information 
booklet used by the bowel scope screening program [16]. 
Results from the second stage of the randomized con-
trolled trial have not previously been examined.
This study reports the “additional” and “overall” 
uptake of bowel scope screening following the second 
reminder. Our specific aims were to (i) examine whether 
a second self-referral reminder increased the uptake 
of screening among former nonparticipants; (ii) assess 
the cumulative effect of the two self-referral reminders 
combined; and (iii) test whether the effect of the theo-
ry-based leaflet on participation was sustained after the 
delivery of a second reminder.
Methods
Study Population, Design, and Trial Setting
We performed a single-blinded, randomized, controlled 
trial with three parallel arms in the London boroughs 
of Brent and Harrow. One thousand three hundred and 
eighty-three men and women randomly selected from a 
weekly variable total of nonparticipants were randomized 
(using simple pseudo-random allocation methods) to 
receive either (1:1:1) no reminder (control, n  =  461), a 
12-month self-referral reminder and standard infor-
mation booklet (Reminder and Standard Information 
Booklet, n = 461), or a 12-month self-referral reminder 
and theory-based leaflet designed using the Behavior 
Change Wheel (Reminder and Theory-Based Leaflet, 
n  =  461). Anyone who did not attend an appointment 
within 12 weeks of being sent the 12-month reminder (or 
no reminder in the case of the control) was re-assessed 
for eligibility 24 months after their initial invitation (i.e., 
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12 months after the first reminder). Individuals who had 
(i) taken part in screening, (ii) registered with a general 
practice outside of the London boroughs of Brent and 
Harrow, or (iii) died were excluded. The remaining popu-
lation were considered “eligible” and assigned to receive 
the same treatment they received 12 months previous.
Because individuals were assigned to receive no re-
minder or a self-referral reminder with one of two leaf-
lets, it was not possible to blind them to the treatment 
they received. In terms of the study setting, the London 
boroughs of Brent and Harrow have below-average up-
take and contain some of the most ethnically diverse and 
socioeconomically deprived areas in England [17].
Procedures
Eligibility was re-assessed using routine data stored on 
the National Health Service Bowel Cancer Screening 
System: an electronic system that provides up-to-date 
uptake data for individuals enrolled in the national 
screening program [18]. Individuals in both reminder 
groups were able to book an appointment by returning an 
“appointment-request-slip” to St Mark’s Bowel Cancer 
Screening Centre (the screening center where appoint-
ments for people living in Brent and Harrow take place), 
thereby initiating a call from a member of the admin-
istrative team to arrange an appointment, or by calling 
the screening center directly on the Freephone number 
provided in the reminder letter. Anyone not responding 
to the “24-month” self-referral reminder within 4 weeks 
was sent a “follow-up” reminder, which also included 
an appointment-request slip, the allocated information 
leaflet, and a Freepost return envelope addressed to St 
Mark’s Bowel Cancer Screening Centre. Individuals 
were given an additional 8 weeks to respond before their 
attendance was assessed on the Bowel Cancer Screening 
System. Anyone referring for an appointment after this 
time was excluded from the study results, but was still 
offered an appointment. Individuals who referred for 
bowel scope screening were sent a pre-appointment text 
message and telephone call (where a mobile/home tele-
phone number was available), as per routine practice.
Intervention Development
The intervention strategy was informed by the Behavior 
Change Wheel [12], which was used (in conjunction with 
the Behavior Change Technique Taxonomy [19]) to iden-
tify the putative targets for change and the behavior 
change techniques likely to affect those targets. We began 
by defining the problem in behavioral terms (see online 
Supplementary material for the completed worksheets), 
before selecting and specifying the target behavior and 
identifying what needed to change (in COM-B terms) for 
the behavior to occur. We then identified the intervention 
functions and policy categories that would be most likely 
to bring about the desired change and reviewed the pos-
sible behavior change techniques and modes of delivery 
that could be used to deliver them.
After identifying the intervention strategy (Table  1), 
we developed the intervention content. We did this by 
the following methods: (i) reviewing the literature exam-
ining the perceived barriers and benefits of screening, (ii) 
interviewing previously screened adults, and (iii) contact-
ing the local primary care cancer leads to obtain a local 
primary care endorsement. An overview of these activi-
ties and how they were used to develop the intervention 
content/deliver the behavior change techniques under-
pinning the intervention strategy is provided in Table 2.
Initial versions of the intervention materials were devel-
oped by Partners in Creation: a social marketing company 
that specializes in the development of health behavior 
change interventions [20]. We provided them with a brief  
outlining the intervention strategy/content described in 
Tables 1 and 2. The drafted materials were then tested in 
a co-design workshop in which screening eligible adults 
from the London boroughs of Brent and Harrow (n = 4; 
3 men, 1 woman; aged 55–58  years) gave feedback to 
Table 1 Summary of the intervention strategy arrived at through the behavior change wheel intervention design process
Intervention functions
COM-B components 
served by the intervention 
functions
Selected behavior change 
techniques
Policy categories through which 
behavior change techniques can be 
delivered Mode of delivery
Modeling Social opportunity Demonstration of the 
behavior
Adding objects to the 
environment
Prompts/cues
Credible source
Information about health 
consequences
Instruction on how to per-
form behavior
Pros and cons
Communication/marketing Leaflets
Environmental 
restructuring
Physical opportunity
Social opportunity
Persuasion Reflective motivation
Education Psychological capability
Reflective motivation
Enablement Psychological capability
Physical opportunity
Social opportunity
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inform future iterations of the materials. Revised versions 
were then presented to individuals who were either the 
eligible age or approaching the eligible age for screening 
(n = 20; 12 women, 8 men, aged 50–59 years) and feed-
back obtained through interviews conducted by a member 
of the University College London (UCL) research team. 
The final materials used in the trial are described under 
Intervention Development.
24-Month reminder
The 24-month reminder was a personally addressed letter 
from St Mark’s Bowel Cancer Screening Centre that 
invited recipients to make an appointment by returning 
an “appointment-request-slip” or calling the Freephone 
number for St Mark’s Bowel Cancer Screening Centre 
(see online Supplementary material). The reminder also 
gave recipients the option to express a preference for the 
day and time of the appointment and the gender of the 
practitioner performing the test.
Theory-based leaflet
The theory-based leaflet was a locally tailored leaflet 
designed to promote bowel scope screening attendance 
at St Mark’s Hospital in London. The leaflet included 
testimonials from individuals previously screened at the 
center, as well as a primary care endorsement of the 
screening test and a list of the benefits of having the test 
(see online Supplementary material).
Follow-up reminder
The follow-up reminder was a personally addressed let-
ter from St Mark’s Bowel Cancer Screening Centre that 
reiterated the opportunity to self-refer for screening up 
until the age of  60 (see online Supplementary material). 
It was included on the basis that additional reminders/
prompts have been shown to have benefits over and 
above those of  single reminders used by themselves [21]. 
The timing for the follow-up reminder was based on the 
program reminder, which is sent 4 weeks after the first 
contact.
Standard information booklet
The standard information booklet was the same 16-page 
booklet sent with the initial invitation as part of the na-
tional screening program (available from https://www.
gov.uk/government/uploads/system/uploads/attach-
ment_data/file/423928/bowel-scope-screening.pdf). The 
standard information booklet was developed by King’s 
Health Partners, who developed the booklet in accord-
ance with the principles put forth by England’s National 
Health Service informed choice initiative [22].
Measures
Routinely available data stored on the Bowel Cancer 
Screening System were used to verify self-referral and 
attendance 4 and 12 weeks following the distribution 
Table 2 Overview of the intervention design
Behavior change technique Definition Examples of use
Pros and cons Advise the person to identify reasons for  
wanting (pros) or not wanting (cons) to  
change behavior
A list of the benefits of bowel scope screening was added 
to the leaflet
Demonstration of the 
behavior
Provide an observable sample of the  
performance of the behavior, directly in  
person or indirectly (e.g., via film, pictures)  
for the person to aspire to or imitate
Testimonials of people who had performed the behavior 
were added to the leaflet
Credible source Present verbal or visual communication from a 
credible source in favor or against the  
behavior
A primary care endorsement from the General Practice 
Cancer Lead endorsing the National Health Service 
Bowel Scope Screening program was added to the 
leaflet
Prompts/cues Introduce or define environmental or social 
stimulus with the purpose of prompting 
or cueing the behavior. The prompt or cue 
would normally occur at the time or place of 
performance
A prompt was added to the intervention strategy by 
developing a “self-referral” reminder letter and a 
“follow-up” reminder letter
Instruction on how to  
perform a behavior
Advise or agree on how to perform a behavior Instructions on how to self-refer for bowel scope screen-
ing were added to the reminder letter
Adding objects to the 
environment
Add objects to the environment in order to  
facilitate performance of the behavior
Several “objects” or facilitators were added to the re-
minder letters, including an “appointment-request 
slip” and a Freepost return envelope
Information about health 
consequences
Provide information (e.g., written, verbal,  
visual) about health consequences of  
performing the behavior
Information about the health consequences of bowel 
scope screening (e.g., reduced risk of colorectal cancer 
incidence and death) was added to the reminder letters
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of  the 24-month self-referral reminder letter. The 
Bowel Cancer Screening System was also consulted to 
obtain the eligibility of  each person, as well as their 
gender (male, female), area (Brent, Harrow), and ini-
tial episode status (did not respond, did not attend). 
For individuals who self-referred for an appointment, 
the Bowel Cancer Screening System was additionally 
consulted to obtain the method of  referral (by letter, 
by telephone) and whether they received a pre-ap-
pointment text message and/or telephone call (coded 
as “received a pre-appointment reminder: yes/no”). 
Lastly, for individuals who attended an appointment, 
the Bowel Cancer Screening System was consulted to 
obtain the clinical outcome and thereby the proportion 
of  people who had one or more precancerous lesions 
(adenomas) detected.
An area-based socioeconomic deprivation score was 
generated for each person by converting their postcode 
into a score on the 2010 Index of Multiple Deprivation 
[23]. Area-level Index of Multiple Deprivation scores 
were then categorized into tertiles of their regional dis-
tributions to enable comparisons between the most and 
least deprived areas.
Sample Size
The primary outcome was the overall uptake of screen-
ing within each group 12  weeks after the delivery of 
the second reminder (sent 24  months after the initial 
invitation). A  sample size of 420 men and women per 
trial arm was required to detect a difference in uptake 
from 10.7% to 17.7% [24] in the Reminder and Standard 
Information Booklet and Reminder and Theory-Based 
Leaflet groups, respectively (α = 0.05; β = 0.2). This was 
increased to 460 per arm to account for dropout during 
reminder intervals, giving a total sample size require-
ment of n = 1,380.
Analysis
The number and percentage of patients screened within 
12 weeks of the second reminder are presented with two-
sided 95% confidence intervals (CIs), constructed using 
exact methods based on the binomial distribution. Odds 
ratios (ORs), adjusted ORs (aORs), and 95% CIs com-
paring the uptake in each group were calculated using 
univariable and multivariable logistic regression to adjust 
for baseline characteristics. Bonferroni corrections and 
an adjusted significance level of 0.015 were used to 
account for multiple comparisons. Subgroup analyses 
were carried out to explore possible associations between 
not attending a confirmed appointment and (i) baseline 
characteristics, (ii) method of referral, and (iii) receipt 
of a pre-appointment text/telephone call. The adenoma 
detection rate was reported using descriptive statistics. 
The cumulative data were analyzed on an intention-to-
treat basis using SPSS (ver.24).
Cost Analysis
We calculated the cost per additional attendee by divid-
ing the cost of the self-referral reminder and follow-up 
reminder (with the standard information booklet and 
theory-based leaflet separately) by the number of people 
who attended screening at 12 and 24  months. We also 
performed a sensitivity analysis by calculating the range 
of variation of the cost estimates within the CIs of the 
participation rates (calculated using exact methods based 
on the binomial distribution).
Ethics
The study was approved by the North-East Tyne & 
Wear South Research Ethics Service (Ref: 15/NE/0043) 
and was registered with the International Standard 
Randomized Controlled Trials Number Registry for 
transparency (trial ID: ISRCTN44293755).
Results
Sample Characteristics
This study took place between February and August, 
2016, with follow-up until October, 2016. In total, 
1,264 (91.4%) out of  1,383 men and women from the 
initial sample were re-assessed for inclusion in this 
analysis (Fig.  1). One hundred and nineteen (8.6%) 
were known to have already taken part in screening 
and were not assessed for this reason. Of  the 1,264 
adults who were re-assessed, 8 (0.6%) had died, and 38 
(2.8%) were no longer registered with a general prac-
tice in the London boroughs of  Brent and Harrow, 
leaving a total sample size of  1,218 men and women 
who were eligible for inclusion across all three study 
groups (control, n  =  453; Reminder and Standard 
Information Booklet, n = 399; Reminder and Theory-
Based Leaflet, n = 366).
The basic attributes of each group are presented in 
Table  3. All participants were aged 57 because of the 
study design. Most (53.4%) were females (n  =  650), 
registered with a general practice in the London borough 
of Brent (n = 816; 67.0%), and did not respond to the ini-
tial invitation (n = 1,072, 88.0%).
Uptake (24-Month Reminder)
In total, 50 (4.1%) men and women who received the 
24-month reminder attended a screening appointment 
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across all three study groups. A  further 7 (0.6%) made 
an appointment, but either did not attend (n = 4) or can-
celled (n = 3), leaving 1,161 (95.3%) individuals who nei-
ther made nor attended an appointment.
The percentage of people who booked and attended 
an appointment within each group was 0.4% (n = 2, 95% 
CI = 0.0–1.6), 4.8% (n = 19, 95% CI = 2.9–7.3), and 7.9% 
(n  =  29, 95% CI  =  5.4–11.2) in the control, Reminder 
and Standard Information Booklet, and Reminder and 
Theory-Based Leaflet groups respectively. Sending a 
second self-referral reminder 24 months after the initial 
invitation therefore further increased screening uptake 
and was significantly more effective than usual care.
Uptake (12- and 24-Month Reminder Combined)
In the combined data, we found that 169 (12.2%) men 
and women had booked and attended an appoint-
ment across all three study groups (Table 4). A further 
43 (3.1%) made an appointment, but subsequently did 
not attend (n = 25) or canceled (n = 18), leaving 1,171 
(84.7%) who neither made nor attended an appointment. 
There was strong evidence of differences in booked and 
attended appointments between the reminder groups and 
the control (Table 5). A total of 67 individuals (14.5%) 
in the Reminder and Standard Information Booklet 
group and 99 individuals (21.5%) in the Reminder and 
Theory-Based Leaflet group attended an appointment, 
compared with only 3 (0.7%) in the control (OR = 25.96, 
95% CI  =  8.10–83.18, p  <  .001 and OR  =  41.75, 95% 
CI  =  13.13–132.76, p  <  .001 for the Reminder and 
Standard Information Booklet and Reminder and 
Theory-Based Leaflet groups, respectively). There was 
also strong evidence of a difference in uptake between 
the reminder groups, with individuals in the Reminder 
and Theory-Based Leaflet group being significantly 
more likely to attend an appointment than individuals in 
the Reminder and Standard Information Booklet group 
(OR = 1.61, 95% CI = 1.14–2.26, p = .006).
Results were similar after adjusting for baseline 
characteristics in the multivariable analysis (Table  5), 
with strong evidence of differences in uptake between 
the reminder groups and the control (Reminder and 
Standard Information Booklet vs. control: aOR = 26.14, 
95% CI  =  8.14–83.95, p  <  .001; Reminder and 
Theory-Based Leaflet vs. control: aOR  =  46.91, 95% 
Fig. 1. CONSORT diagram.
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CI = 14.68–149.93, p < .001). After adjusting for base-
line characteristics, there remained a significant dif-
ference in participation between intervention groups, 
with individuals in the Reminder and Theory-Based 
Leaflet group being more likely to book and attend 
an appointment than individuals in the Reminder and 
Standard Information Booklet group (aOR = 1.80, 95% 
CI = 1.26–2.55; p < .001). There was also strong evidence 
of a difference in uptake by initial episode status after 
adjusting for study group and other baseline character-
istics, with former nonattenders (i.e., people who did not 
attend) being more likely to book and attend an appoint-
ment than former nonresponders (i.e., people who did 
not respond); uptake was 11.4% and 20.3%, respectively 
(aOR = 2.60, 95% CI = 1.55–4.36; p < .001). There was 
no evidence of an association between screening uptake 
and gender, regional Index of Multiple Deprivation ter-
tile, or area (Table 6).
Confirmed Appointments (12- and 24-Month Reminder 
Combined)
A total of 43 individuals booked an appointment but did 
not attend. A significant difference in attendance among 
people who self-referred was observed between men and 
women (84.4% vs. 74.5%), with men being more likely to 
attend their appointment than women (aOR = 2.06, 95% 
CI = 1.01–4.23, p = .05). A similar difference in uptake 
was observed between people who received a pre-appoint-
ment reminder and people who did not (83.6% vs. 73.6%), 
although this did not reach statistical significance in the 
multivariable analysis (aOR = 1.70; 95% CI = 0.84–3.44, 
p = .14). There was no evidence of differences in nonat-
tendance for any of the other variables included in the 
analysis, including initial episode status, method of refer-
ral and area (see online Supplementary material).
Adenoma Detection Rate (12- and 24-Month Reminder 
Combined)
Of the 169 men and women who attended an appoint-
ment and were screened, 14 (8.3%) had one or more ade-
nomas detected, 7 of whom had adenomas that met the 
clinical criteria for colonoscopy and subsequently under-
went further examination. One person was diagnosed 
with cancer and was referred for treatment because 
of their diagnosis. In the multivariable regression (see 
online Supplementary material), there were no statisti-
cal differences in the proportion of individuals who had 
Table 3 Baseline characteristics
Control
(n = 453)
Rem-SIB
(n = 399)
Rem-TBL
(n = 366)
Total
(n = 1,218)
χ2
(p Value)
Gender n (%)
 Female 255 (56.3) 213 (53.4) 182 (49.7) 650 (53.4) 3.51
(.173) Male 198 (43.7) 186 (46.6) 184 (50.3) 568 (46.6)
Area n (%)
 Brent 300 (66.2) 259 (64.9) 257 (70.2) 816 (67.0) 2.62
(.269) Harrow 153 (33.8) 140 (35.1) 109 (29.8) 402 (33.0)
Tertile of deprivation (Index of Multiple Deprivation Score) n (%)
 Tertile 1
(0.00–17.68)
148 (32.7) 128 (32.1) 104 (28.4) 380 (31.2) 2.14
(.710)
 Tertile 2
(17.69–27.50)
164 (36.2) 141 (35.3) 142 (38.8) 447 (36.7)
 Tertile 3
(27.51–80)
137 (30.2) 126 (31.6) 115 (31.4) 378 (31.0)
 Missing 4 (0.9) 4 (1.0) 5 (1.4) 14 (1.1)
Initial episode status n (%)
Initial nonresponder 404 (89.2) 342 (85.7) 326 (89.1) 1,072 (88.0) 2.98
(.226)Initial nonattender 49 (10.8) 57 (14.3) 40 (10.9) 146 (12.0)
Rem-SIB Reminder and Standard Information Booklet; Rem-TBL Reminder and Theory-Based Leaflet.
Table 4 Uptake at 12 and 24 months by trial arm
Uptake % (95% CI)
12 Months 24 Months
Control (n = 461) 0.2 (0.0%–1.2%) 0.7 (0.2%–2.0%)
Rem-SIB (n = 461) 10.4 (7.8%–13.6%) 14.5 (11.4%–18.1%)
Rem-TBL (n = 461) 15.2 (12.1%–18.8%) 21.5 (17.8%–25.5%)
CI confidence interval; Rem-SIB Reminder and Standard 
Information Booklet; Rem-TBL Reminder and Theory-Based 
Leaflet.
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adenomas detected by trial arm or baseline characteris-
tics (all p values >.05).
Costs
The estimated cost of the interventions per additional 
person attending screening at 12  months were £8.37 
(range: £6.38–£11.17) in the Reminder and Standard 
Information Booklet group and £8.75 (range: £7.05–
£11.14) in the Reminder and Theory-Based Leaflet 
group (see online Supplementary material for a break-
down of the intervention costs for each group). Costs 
for both interventions were significantly higher at 
24  months (95% CIs did not overlap), with at an esti-
mated cost per additional person attending screening 
of £18.31 (range: £12.00–£29.00) in the Reminder and 
Standard Information Booklet group and £16.93 (range: 
£11.97–£24.55) in the Reminder and Theory-Based 
Leaflet group (see online Supplementary material for a 
breakdown of the intervention costs).
Discussion
The results of this study provide strong evidence to sup-
port the use of a second self-referral reminder within 
the National Health Service bowel scope screening 
program and highlight an additional benefit to includ-
ing a bespoke theory-based leaflet designed using the 
Behavior Change Wheel (the overall uptake was 0.7%, 
14.5%, and 21.5% in the control, Reminder and Standard 
Information Booklet and Reminder and Theory-Based 
Leaflet groups, respectively).
At the current rate of attendance (43%) [4], the inclu-
sion of two self-referral reminders within the National 
Health Service bowel scope screening program would 
increase uptake by ~8–12 percentage-points (estimated 
by multiplying the proportion of adults not attending 
an initial appointment [57%] by the proportion of adults 
attending an appointment following the delivery of the 
24-month reminder with either the standard information 
booklet [14.5%] or the theory-based leaflet [21.5%]), de-
pending on which of the two leaflets were adopted. Given 
that uptake was consistent between men and women, as 
well as between tertiles of area-level deprivation, it seems 
unlikely that implementing these reminders with either 
leaflet would exacerbate existing inequalities in uptake 
[4]. Indeed, it is possible that implementing these remind-
ers could in fact reduce inequalities in uptake, given that 
the proportion of nonparticipants living in the most 
deprived quintile of areas is greater than the propor-
tion living in the least deprived quintile of areas (48% 
vs. 68%) [4].
While uptake did not vary by gender or tertile of 
area-level deprivation, it did vary by initial episode sta-
tus, with initial nonattenders being more likely to book 
and attend an appointment than initial nonresponders 
(20.3% vs. 11.4%). One possible explanation for this is 
that initial nonattenders (who perceive fewer barriers 
and more benefits to screening than initial nonrespond-
ers) are qualitatively similar to screened adults, but have 
difficulty translating their intentions into action due to 
circumstantial aspects, such as poor health [25]. Indeed, 
previous research by Ferrer and colleagues [26] has 
shown that participation in colorectal cancer screening 
Table 5 Self-referral and uptake by trial arm (12 and 24 months combined)
n (%)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Made an appointment comparisons
 Control vs. Rem-SIB 3 vs. 83
(0.7 vs. 18.0)
33.52**
(10.51–106.92)
33.9**
(10.60–108.36)
 Control vs. Rem-TBL 3 vs. 126
(0.7 vs. 27.3)
57.42**
(18.12–182.00)
65.25**
(20.48–207.90)
 TMR-SIB vs. Rem-TBL 83 vs. 126
(18.0 vs. 27.3)
1.71**
(1.25–2.34)
1.93**
(1.39–2.66)
Attended an appointment comparisons
 Control vs. Rem-SIB 3 vs. 67
(0.7 vs. 14.5)
25.96**
(8.10–83.18)
26.14**
(8.14–83.95)
 Control vs. Rem-TBL 3 vs. 99
(0.7 vs. 21.5)
41.75**
(13.13–132.76)
46.91**
(14.68–149.93)
 TMR-SIB vs. Rem-TBL 67 vs. 99
(14.5 vs. 21.5)
1.61*
(1.14–2.26)
1.80**
(1.26–2.55)
n = 461 for all groups reported. Adjusted ORs and 95% CIs are adjusted for gender, area, deprivation, and initial episode status.
ORs odds ratios; CI confidence interval; Rem-SIB Reminder and Standard Information Booklet; Rem-TBL Reminder and Theory-Based 
Leaflet.
*p ≤ .01; **p ≤ .001. 
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is a behavioral process comprised of several qualitatively 
distinct stages through which individual transition based 
on their readiness to screen. Each stage is thought to be 
strongly associated with a specific set of attitudes and 
beliefs toward the test, and it may be that the interven-
tions used in our study were more effective at facilitat-
ing forward stage transitions in initial nonattenders by 
addressing issues that were specific to them.
Our study also found that, among individuals who 
made an appointment, women were less likely to attend 
screening than men (74.5% vs. 84.5%). This was consist-
ent with previous research in which women who stated 
that they “probably would” or “definitely would” attend 
screening were less likely to attend than their male coun-
terparts [25]. Given its position within the screening 
pathway, it seems likely that these differences in uptake 
between men and women are due to the enema, which 
has previously been reported as a major barrier for 
women, but not men [27].
In terms of the clinical findings, the adenoma detec-
tion rate (8.3%) was similar to that of initial attenders 
(i.e., 9.8%) [7]. The rate was also consistent across re-
minder groups, irrespective of the information used, 
suggesting that both materials were effective at attract-
ing individuals with colorectal pathology. With regards 
to reminder intervals (i.e., 12  months vs. 24  months), 
the study was underpowered to detect whether the total 
number of adenomas detected increased. Further studies 
with larger sample sizes are required to test this.
Finally, few previous studies have been able to dem-
onstrate the added value of theory-based materials on 
colorectal cancer screening rates [28], particularly with 
regards to flexible sigmoidoscopy screening [8]. The find-
ing that the theory-based leaflet (albeit predominantly 
with the first reminder) used in this study was effective is, 
therefore, highly encouraging. Not only does it demon-
strate that such materials designed using theory can be 
effective, but that they can be implemented in ways that 
do not contravene General Medical Council guidelines 
for informed consent (e.g., by being sent after the full 
suite of information has been received by the patient). 
Furthermore, the findings from the present study provide 
Table 6 Self-referral and uptake by baseline characteristics (12 and 24 months combined)
Made an 
appointment
n (%)
Unadjusted OR
(95% CI)
Adjusted
OR
(95% CI)
Attended an  
appointment
n (%)
Unadjusted OR
(95% CI)
Adjusted
OR
(95% CI)
Gender
 Femalea (n = 727) 109 (15.0) – – 82 (11.3) – –
 Male
(n = 656)
103 (15.7) 1.06 (0.79–1.42) 0.96 (0.71–1.32) 87 (13.3) 1.20 (0.87–1.66) 1.14 (0.81–1.60)
Area
 Brenta
(n = 926)
134 (14.5) – – 103 (11.1) – –
 Harrow
(n = 457)
78 (17.1) 1.22 (0.90–1.65) 1.26 (0.84–1.89) 66 (14.4) 1.35 (0.97–1.88) 1.44 (0.93–2.24)
Deprivation
 Tertile 1a
(n = 429)
70 (16.3) – – 58 (13.5) – –
 Tertile 2
(n = 505)
74 (14.7) 0.88 (0.62–1.26) 0.97 (0.63–1.49) 55 (10.9) 0.78 (0.53–1.16) 0.92 (0.58–1.48)
 Tertile 3
(n = 435)
67 (15.4) 0.93 (0.65–1.35) 1.09 (0.68–1.76) 56 (12.9) 0.95 (0.64–1.40) 1.22 (0.73–2.04)
Initial episode status
 Initial 
nonrespondera
(n = 1,255)
181 (14.4) – – 143 (11.4) – –
 Initial
nonattender
(n = 128)
31 (24.2) 1.90* (1.23–2.93) 2.67** (1.63–4.37) 26 (20.3) 1.98* (1.25–3.15) 2.60** (1.55–4.36)
Adjusted ORs and 95% CIs are adjusted for trial arm and all other covariates in the table.
OR odds ratio; CI confidence intervals; Rem-SIB Reminder and Standard Information Booklet; Rem-TBL Reminder and Theory-Based 
Leaflet.
aReference category.
*p ≤ .01; **p ≤ .001.
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evidence to support the use of the Behavior Change 
Wheel as a framework for developing theory-based 
interventions. Had we used another approach, the study 
materials may have been similarly ineffective to those 
described in the previous literature.
Strengths
This study had several strengths. First, it used a rand-
omized design, which is considered the gold standard 
in terms of  evaluating the effectiveness of  public health 
interventions [29]. Second, it is the first study to exam-
ine whether self-referral reminders can increase the 
uptake of  bowel scope screening and, as such, is the first 
study to show that these are effective without being vul-
nerable to bias and confounding present in other stud-
ies. Finally, the study setting (St Mark’s Bowel Cancer 
Screening Centre) serves an ethnically diverse popu-
lation from a range of  socioeconomic areas and, as a 
result, the findings are likely to be generalizable to other 
London boroughs and international urban settings 
struggling to reach the European target for acceptable 
participation [30].
Limitations
As well as several strengths, this study had a number of 
important limitations: the main one being that we only 
examined the impact of the interventions at a single 
center and another being that we only selected a pro-
portion of former nonparticipants for inclusion in the 
trial—not the entire eligible population. An important 
next step, therefore, would be to investigate the feasibility 
of rolling out these reminders across the entire eligible 
cohort of nonparticipants. On the basis that the first re-
minder was effective, the English National Health Service 
have commissioned St Mark’s Hospital to carry out this 
work at the London center. It is our hope that after the 
publication of the current findings, the English National 
Health Service will also commission St Mark’s Hospital 
to implement and evaluate the use of a 24-month re-
minder as well.
Another important caveat of our study is that, while 
our leaflet was largely driven by theory-based insights, 
some of its characteristics were based on anecdotal evi-
dence, or previous empirical observations. For example, 
the theory-based leaflet was shorter and had a lower 
readability score on the basis of previous research high-
lighting barriers to engaging with written information 
about colorectal cancer screening by individuals with 
both low and high literacy [31, 32].  Without additional 
studies exploring the reasons why people self-referred for 
screening (in both groups), it is not possible to say why the 
theory-based leaflet was more effective. Future studies 
using questionnaires to examine which of the COM-B 
components were affected by the study materials could 
also help elucidate how the interventions facilitated 
behavior change. A factorial randomized controlled trial 
comparing multiple versions of the theory-based leaflet 
would ultimately be needed to disentangle which of the 
behavior change techniques helped to facilitate behavior 
change and thereby self-referral and uptake.
Finally, our study was limited to routine data stored 
on the Bowel Cancer Screening System. As such, it was 
not possible to include other potential predictors of 
responding to the screening invite and attendance at 
screening (e.g., previous bowel symptoms, and ethnicity) 
[25].
Conclusion
Sending former nonparticipants a self-referral reminder 
12 and 24  months after their initial invitation was ef-
fective at improving uptake and was enhanced by the 
inclusion of a theory-based leaflet developed using the 
Behavior Change Wheel. Future studies should focus 
on the feasibility of implementing these interventions 
across multiple centers and the wider population of eli-
gible adults.
Supplementary Material
Supplementary material is available at Annals of 
Behavioral Medicine online.
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